Table 2.
% with moderate/strong CD68 staining | % with moderate/strong OPG staining | Co-occurrence of moderate/strong CD68 and OPG staining |
---|---|---|
95.7 | 78.3 | 35 out of 46 tumors = 76.1% |
CD68 and OPG protein levels were assessed by immunohistochemistry in tissue microarray slides containing human patient primary breast cancer samples (see Methods). Two left columns: data is shown as the percentage of samples presenting with moderate/strong CD68 and OPG staining. Right column: co-occurrence of CD68 and OPG staining represent the detection of moderate/strong expression of both CD68 and OPG within the same patient sample